Update on psoriasis: A review

Jagadish P Rajguru, Deepthi Maya, Dinesh Kumar, Prerna Suri, Shweta Bhardwaj, Nishitkumar D Patel, Jagadish P Rajguru, Deepthi Maya, Dinesh Kumar, Prerna Suri, Shweta Bhardwaj, Nishitkumar D Patel

Abstract

Psoriasis is a disease characterized by the presence of papules and plaques over the surface of skin with variable morphology, distribution and severity. The lesions of psoriasis are distinct from these other entities and are classically very well circumscribed, circular, red papules or plaques with a grey or silvery-white, dry scale. In addition, the lesions are typically distributed symmetrically on the scalp, elbows, knees, lumbosacral area, and in the body folds. The oral manifestations of psoriasis may involve the oral mucosa or the tongue. The dorsal surface of the tongue shows characteristic red patches surrounded with a yellow white border. The relationship between eye lesions and psoriasis are the current findings in the literature. The ocular complications along with the several extracutaneous manifestations are common complications seen in psoriasis. The pathogenesis of exact relationship between these two is still controversial. Immunological studies have shown a positive relationship between T helper cells and uveitis. Various signs and symptoms of ocular psoriasis may be overlooked. Thus, a complete understanding of ophthalmic involvement is important to the comprehensive care of patients with psoriasis. Almost any part of the body can be affected in psoriasis, but the ophthalmic complications of psoriasis usually remain clinically subtle. This review highlights the various manifestations of psoriasis with their clinical sign and symptoms.

Keywords: Inflammatory cells; manifestations; patches; psoriasis.

Conflict of interest statement

There are no conflicts of interest.

Copyright: © 2020 Journal of Family Medicine and Primary Care.

References

    1. Talaee R, Hajheydari Z, Moghaddam AY, Moraveji SA, Ravandi BF. Prevalence of oral mucosal lesions and their association with severity of psoriasis among psoriatic patients referred to dermatology clinic: A cross-sectional study in Kashan/Iran. Open Access Maced J Med Sci. 2017;5:978–82.
    1. Kolli SR, Boda N, Reddy EA. Ocular menifestation in psoriasis. Natl J Med Dent Res. 2016;4:101–4.
    1. Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A. Psoriasis induced by anti–tumor necrosis factor therapy: A paradoxical adverse reaction. Arthritis Rheumatism. 2005;52:2513–8.
    1. Okamoto F, Umebayasi Y, Ohtsuka F, Hommura S. Factors associated with increased aqueous flare in psoriasis. Jpn J Ophthalmol. 2001;45:172–6.
    1. Campanati A, Neri P, Giuliodori K, Arapi I, Carbonari G, Borioni E, et al. Psoriasis beyond the skin surface: A pilot study on the ocular involvement. Int Ophthalmol. 2015;35:331–40.
    1. Rehal B, Modjtahedi BS, Morse LS, Schwab IR, Maibach HI. Ocular psoriasis. J Am Acad Dermatol. 2011;65:1202–12.
    1. Au S-C, Yaniv S, Gottlieb AB. Psoriatic eye manifestations. Psoriasis Forum. 2011;17;3:169–79.
    1. Zohreh H, Leila S, Soheila S. Management of psoriasis in children: A narrative review. J Pediatr Rev. 2015;3:e131.
    1. Zargari O. The prevalence and significance of fissured tongue and geographical tongue in psoriatic patients. Clin Exp Dermatol. 2006;31:192–5.
    1. Das RP, Jain AK, Ramesh V. Current concepts in the pathogenesis of psoriasis. Indian J Dermatol. 2009;54:7–12.
    1. Mehlis SL, Gordon KB. The immunology of psoriasis and biological immunotherapy. J Am Acad Dermatol. 2003;49(2 Suppl):S44–50.
    1. Joshi R. Immunopathogenesis of psoriasis. India J Dermatol Venereol Leprol. 2004;70:1.
    1. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol. 2002;2:151–61.
    1. McGregor JM, Barker JN, Ross EL, MacDonald DM. Epidermal dendritic cells in psoriasis possess a phenotype associated with antigen presentation: In situ expression of beta 2-integrins. J Am Acad Dermatol. 1992;27:383–8.
    1. Longo R, Sarmiento R, Fanelli M, Capaccetti B, Gattuso D, Gasparini G. Anti-angiogenic therapy: Rationale, challenges and clinical studies. Angiogenesis. 2002;5:237–56.
    1. Creamer D, Sullivan D, Bicknell R, Barker J. Angiogenesis in psoriasis. Angiogenesis. 2002;5:231–6.
    1. El-Domyatic M, Barakat M, Abdel-Razel R. Expression of apoptosis regulating proteins, P53 and Bcl-2, in Psoriasis. J Egypt Wom Dermatol Soc. 2006;3:46–51.
    1. Stern RS, Thibodeau LA, Kleinerman RA, Parrish JA, Fitzpatrick TB. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med. 1979;300:809–13.
    1. Durrani K, Foster CS. Psoriatic uveitis: A distinct clinical entity? Am J Ophthalmol. 2005;139:106–11.
    1. Monnet D, Breban M, Hudry C, Dougados M, Brézin AP. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: A study of 175 cases. Ophthalmology. 2004;111:802–9.
    1. Stern RS. Ocular lens findings in patients treated with PUVA. J Invest Dermatol. 1994;103:534–8.
    1. Erbagci I, Erbagci Z, Gungor K, Bekir N. Ocular anterior segment pathologies and tear film changes in patients with psoriasis vulgaris. Acta Medica Okayama. 2003;57:299–304.
    1. Venugopal DC, S S, Narasimhan M. A rare case of intraoral psoriasis. Cureus. 2019;11:e5204.
    1. Falto-Aizpurua LA, Martin-Garcia RF, Carrasquillo OY, Nevares-Pomales OW, Sánchez-Flores X, Lorenzo-Rios D. Biological therapy for pustular psoriasis: A systematic review. Int J Dermatol. 2019 doi: 101111/ijd. 14671.
    1. Bruce AJ, Rogers RS. Oral psoriasis. Dermatol Clin. 2003;21:99–104.
    1. Reis V, Artico G, Seo J, Bruno I, Hirota SK, Lemos C, et al. Psoriasiform mucositis on the gingival and palatal mucosae treated with retinoic-acid mouthwash. Int J Dermatol. 2013;52:113–5.
    1. Ehsani A, Mortazavi H, Nourmohamadpure P, Azizpour A, Janesar Hoseinie M, Ghaedi F. Oral manifestations in patients with psoriasis: A cross-sectional study. J Skin Stem Cell. 2018;5:e83956.

Source: PubMed

3
Abonner